BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 10536138)

  • 21. Inducible gene inactivation in neurons of the adult mouse forebrain.
    Erdmann G; Schütz G; Berger S
    BMC Neurosci; 2007 Aug; 8():63. PubMed ID: 17683525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inducible site-directed recombination in mouse embryonic stem cells.
    Zhang Y; Riesterer C; Ayrall AM; Sablitzky F; Littlewood TD; Reth M
    Nucleic Acids Res; 1996 Feb; 24(4):543-8. PubMed ID: 8604292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporally and spatially regulated somatic mutagenesis in mice.
    Schwenk F; Kuhn R; Angrand PO; Rajewsky K; Stewart AF
    Nucleic Acids Res; 1998 Mar; 26(6):1427-32. PubMed ID: 9490788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inducible and irreversible control of gene expression using a single transgene.
    Fuhrmann-Benzakein E; García-Gabay I; Pepper MS; Vassalli JD; Herrera PL
    Nucleic Acids Res; 2000 Dec; 28(23):E99. PubMed ID: 11095695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inducible site-specific recombination in the brain.
    Kellendonk C; Tronche F; Casanova E; Anlag K; Opherk C; Schütz G
    J Mol Biol; 1999 Jan; 285(1):175-82. PubMed ID: 9878397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral-mediated temporally controlled dopamine production in a rat model of Parkinson disease.
    Li XG; Okada T; Kodera M; Nara Y; Takino N; Muramatsu C; Ikeguchi K; Urano F; Ichinose H; Metzger D; Chambon P; Nakano I; Ozawa K; Muramatsu S
    Mol Ther; 2006 Jan; 13(1):160-6. PubMed ID: 16182609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts.
    Andersson KB; Winer LH; Mørk HK; Molkentin JD; Jaisser F
    Transgenic Res; 2010 Aug; 19(4):715-25. PubMed ID: 19894134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A chimeric Cre recombinase inducible by synthetic,but not by natural ligands of the glucocorticoid receptor.
    Brocard J; Feil R; Chambon P; Metzger D
    Nucleic Acids Res; 1998 Sep; 26(17):4086-90. PubMed ID: 9705523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen-inducible Cre-mediated recombination in adipocytes.
    Sassmann A; Offermanns S; Wettschureck N
    Genesis; 2010 Oct; 48(10):618-25. PubMed ID: 20715175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
    Jäger R; Maurer J; Jacob A; Schorle H
    Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporally controlled targeted somatic mutagenesis in skeletal muscles of the mouse.
    Schuler M; Ali F; Metzger E; Chambon P; Metzger D
    Genesis; 2005 Apr; 41(4):165-70. PubMed ID: 15789425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse.
    Lau J; Minett MS; Zhao J; Dennehy U; Wang F; Wood JN; Bogdanov YD
    Mol Pain; 2011 Dec; 7():100. PubMed ID: 22188729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tamoxifen-inducible NaV1.8-CreERT2 recombinase activity in nociceptive neurons of dorsal root ganglia.
    Zhao J; Nassar MA; Gavazzi I; Wood JN
    Genesis; 2006 Aug; 44(8):364-71. PubMed ID: 16850455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of tamoxifen-inducible CRE recombinase in Lcn5-CreER
    Xu J; Yao G; Ru Y; Xie S
    Mol Reprod Dev; 2017 Mar; 84(3):257-264. PubMed ID: 28029195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesis.
    Zhang M; Kirsch DG
    Dis Model Mech; 2015 Sep; 8(9):1155-66. PubMed ID: 26183214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inducible site-specific recombination in neural stem/progenitor cells.
    Chen J; Kwon CH; Lin L; Li Y; Parada LF
    Genesis; 2009 Feb; 47(2):122-31. PubMed ID: 19117051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase.
    Danielian PS; Muccino D; Rowitch DH; Michael SK; McMahon AP
    Curr Biol; 1998 Dec; 8(24):1323-6. PubMed ID: 9843687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporally controlled targeted somatic mutagenesis in mouse eye pigment epithelium.
    Mori M; Gargowitsch L; Bornert JM; Garnier JM; Mark M; Chambon P; Metzger D
    Genesis; 2012 Nov; 50(11):828-32. PubMed ID: 22730183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation and characterization of transgenic mice expressing tamoxifen-inducible cre-fusion protein specifically in mouse liver.
    Zhu HZ; Chen JQ; Cheng GX; Xue JL
    World J Gastroenterol; 2003 Aug; 9(8):1844-7. PubMed ID: 12918135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.